Adastra Holdings Ltd C.XTRX

Alternate Symbol(s): XTXXF

Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. The Company extracts and processes cannabis for sale to the recreational and medical markets in Canada using its large-scale extraction facility (the Facility) to produce a variety of products, including vape pens, wax, resin, infused pre-rolls, diamonds and shatter. It serves medical markets and engages in therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are well established with a solid distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., and others.

CSE:XTRX - Post by User

Adastra Holdings Ltd > Adastra Holdings Reports First Quarter Results

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on May 30, 2023 10:28pm

265 Views

Post# 35471526

Adastra Holdings Reports First Quarter Results

Record Q1 2023 gross revenues of $9.5M, increase of 315% from Q1 2022
Record Q1 2023 cash provided by operations of $1.5M, compared to $104K in Q1 2022
Q1 2023 gross profit of $1.7M, increase of 102% from Q1 2022

LANGLEY, BC / ACCESSWIRE / May 30, 2023 / Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to report financial results for the three months ended March 31, 2023.

Adastra Holdings Reports First Quarter Results; Demonstrating Record Quarterly Gross Revenues of $9.5M (accesswire.com)